This inventor holds 2 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: R Bio Co., Ltd., Rnl Bio Co., Ltd., Other. Active years: 2015-2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2015-2018
Title: Jung Youn Jo: Innovator in Stem Cell Research
Introduction
Jung Youn Jo is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of stem cell research, focusing on enhancing the regenerative capacity of stem cells. With a total of 2 patents, his work has the potential to impact various therapeutic applications.
Latest Patents
Jung Youn Jo's latest patents include a culture medium composition for improving the regenerative capacity of stem cells and a stem cell culturing method using the same. The first patent relates to a medium composition that enhances the self-renewal ability of stem cells, which contains apelin. This invention allows for effective culturing of stem cells, enabling them to proliferate without altering their characteristics, while also increasing telomerase activity. The second patent focuses on a cellular therapeutic agent for treating urinary incontinence, which contains stem cells derived from the decidua of the placenta or adipose tissue. These stem cells demonstrate the ability to increase leak point pressure and urethral sphincter contractility, making them valuable for treating urinary incontinence.
Career Highlights
Throughout his career, Jung Youn Jo has worked with notable companies such as RNL Bio Co., Ltd. and R Bio Co., Ltd. His experience in these organizations has contributed to his expertise in stem cell research and development.
Collaborations
Jung Youn Jo has collaborated with esteemed colleagues, including Jeong Chan Ra and Hang Young Lee. These partnerships have furthered his research and innovation in the field of stem cells.
Conclusion
Jung Youn Jo is a dedicated inventor whose work in stem cell research holds promise for advancing medical therapies. His innovative patents and collaborations reflect his commitment to improving regenerative medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile